Home
Kynam Capital Management reported a 9.96% stake in CytomX Therapeutics CTMX · 0 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.96%
- Last report
- 6.9% · filed 26/05/15
- Shares held
- 0 sh
- Class
- Common Stock, $0.00001 par value per share
- Holder
- Kynam Capital Management
- Event date
- 26/06/30
- Filed
- 26/08/14
9.96% stake · +3.1pp from the last report
- Stake
- 9.96%
- Last report
- 6.9%
- Since last report
- +3.1pp
CytomX Therapeutics trades, last 26 weeks
What else happened in CytomX Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Kynam Capital Management's other 5% stake reports
- Kynam Capital Management
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
5.7% stake
0 sh
5.7% stake
Filed 08/14
- Kynam Capital Management
5% stakeVera Therapeutics
5% stakeVera Therapeutics
VERA
4.01% stake
0 sh
4.01% stake
Filed 08/14
- Kynam Capital Management
5% stakeCelldex Therapeutics
5% stakeCelldex Therapeutics
CLDX
6.78% stake
0 sh
6.78% stake
Filed 08/14
- Kynam Capital Management
5% stakeBurning Rock Biotech
5% stakeBurning Rock Biotech
BNR
13.97% stake
0 sh
13.97% stake
Filed 05/15
- Kynam Capital Management
5% stakeCelldex Therapeutics
5% stakeCelldex Therapeutics
CLDX
8.77% stake
0 sh
8.77% stake
Filed 05/15
